Lung Cancer Surgery Trends and Forecast
The future of the global lung cancer surgery market looks promising with opportunities in the hospital, specialty cancer care center, and ambulatory surgical center markets. The global lung cancer surgery market is expected to reach an estimated $5.7 billion by 2030 with a CAGR of 3.4% from 2024 to 2030. The major drivers for this market are rising occurrence of lung cancer, increasing consumer preference towards minimally invasive surgeries, and increasing air pollution levels.
A more than 150-page report is developed to help in your business decisions. Sample figures with some insights are shown below.
Lung Cancer Surgery by Segment
The study includes a forecast for the global lung cancer surgery by product type, surgery, end use, and region.
Lung Cancer Surgery Market by Product Type [Shipment Analysis by Value from 2018 to 2030]:
• Surgical Devices
• Endosurgical Equipment
• Monitoring or Visualizing Equipment
Lung Cancer Surgery Market by Surgery [Shipment Analysis by Value from 2018 to 2030]:
• Robotic Surgery
• Thoracotomy
• Video Assisted Surgery
• Percutaneous Surgery
• Endobronchial Surgery
Lung Cancer Surgery Market by End Use [Shipment Analysis by Value from 2018 to 2030]:
• Hospitals
• Specialty Cancer Care Centers
• Ambulatory Surgical Centers
• Others
Lung Cancer Surgery Market by Region [Shipment Analysis by Value from 2018 to 2030]:
• North America
• Europe
• Asia Pacific
• The Rest of the World
List of Lung Cancer Surgery Companies
Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies lung cancer surgery companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the lung cancer surgery companies profiled in this report include-
• Scanlan International
• Ethicon Endo Surgery
• Covidien
• Trokamed
• Angiodynamics
• Richard Wolf
• BSD Medical
• Siemens Healthcare
• Accuray
• Neomend
Lung Cancer Surgery Market Insights
Lucintel forecasts that surgical device is expected to witness the highest growth over the forecast period.
Within this market, ambulatory surgical center is expected to witness the highest growth over the forecast period.
North America will remain the largest region over the forecast period.
Features of the Global Lung Cancer Surgery Market
Market Size Estimates: Lung cancer surgery market size estimation in terms of value ($B).
Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.
Segmentation Analysis: Lung cancer surgery market size by product type, surgery, end use, and region in terms of value ($B).
Regional Analysis: Lung cancer surgery market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
Growth Opportunities: Analysis of growth opportunities in different product types, surgeries, end uses, and regions for the lung cancer surgery market.
Strategic Analysis: This includes M&A, new product development, and competitive landscape of the lung cancer surgery market.
Analysis of competitive intensity of the industry based on Porter’s Five Forces model.
FAQ
Q1. What is the lung cancer surgery market size?
Answer: The global lung cancer surgery market is expected to reach an estimated $5.7 billion by 2030.
Q2. What is the growth forecast for lung cancer surgery market?
Answer: The global lung cancer surgery market is expected to grow with a CAGR of 3.4% from 2024 to 2030.
Q3. What are the major drivers influencing the growth of the lung cancer surgery market?
Answer: The major drivers for this market are rising occurrence of lung cancer, increasing consumer preference towards minimally invasive surgeries, and increasing air pollution levels.
Q4. What are the major segments for lung cancer surgery market?
Answer: The future of the lung cancer surgery market looks promising with opportunities in the hospital, specialty cancer care center, and ambulatory surgical center markets.
Q5. Who are the key lung cancer surgery market companies?
Answer: Some of the key lung cancer surgery companies are as follows:
• Scanlan International
• Ethicon Endo Surgery
• Covidien
• Trokamed
• Angiodynamics
• Richard Wolf
• BSD Medical
• Siemens Healthcare
• Accuray
• Neomend
Q6. Which lung cancer surgery market segment will be the largest in future?
Answer: Lucintel forecasts that surgical device is expected to witness the highest growth over the forecast period.
Q7. In lung cancer surgery market, which region is expected to be the largest in next 5 years?
Answer: North America will remain the largest region over the forecast period.
Q.8 Do we receive customization in this report?
Answer: Yes, Lucintel provides 10% customization without any additional cost.
This report answers following 11 key questions:
Q.1. What are some of the most promising, high-growth opportunities for the lung cancer surgery market by product type (surgical devices, endosurgical equipment, and monitoring or visualizing equipment), surgery (robotic surgery, thoracotomy, video assisted surgery, percutaneous surgery, and endobronchial surgery), end use (hospitals, specialty cancer care centers, ambulatory surgical centers, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
Q.2. Which segments will grow at a faster pace and why?
Q.3. Which region will grow at a faster pace and why?
Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
Q.5. What are the business risks and competitive threats in this market?
Q.6. What are the emerging trends in this market and the reasons behind them?
Q.7. What are some of the changing demands of customers in the market?
Q.8. What are the new developments in the market? Which companies are leading these developments?
Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?
For any questions related to Lung Cancer Surgery Market, Lung Cancer Surgery Market Size, Lung Cancer Surgery Market Growth, Lung Cancer Surgery Market Analysis, Lung Cancer Surgery Market Report, Lung Cancer Surgery Market Share, Lung Cancer Surgery Market Trends, Lung Cancer Surgery Market Forecast, Lung Cancer Surgery Companies, write Lucintel analyst at email: helpdesk@lucintel.com. We will be glad to get back to you soon.